The antibody VRC01 proves safe for individuals infected with HIV-1, but only modestly controls the virus in participants who stop receiving antiretroviral therapy, report scientists.
The antibody VRC01 proves safe for individuals infected with HIV-1, but only modestly controls the virus in participants who stop receiving antiretroviral therapy, report scientists.